Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001721358 | SCV000530848 | likely benign | not provided | 2020-01-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000464572 | SCV000563201 | benign | Charcot-Marie-Tooth disease dominant intermediate B | 2024-01-29 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000428244 | SCV001159765 | benign | not specified | 2018-08-09 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000428244 | SCV001880112 | benign | not specified | 2021-05-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002411377 | SCV002714903 | likely benign | Inborn genetic diseases | 2020-01-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |